Search - tctmd.com

Displaying 101 - 120 of 156

Sort: Relevancy | Date

Presentation TCT 2017

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip

October 30, 2017

Presentation TCT 2017

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2017

Impact of Antegrade Dissection and Re-entry in Japanese CTO Interventions

Presenter: Masahiko Ochiai, Atsunori Okamura

October 29, 2017

Presentation TCT 2017

IVUS-Guided Rewiring in the Antegrade Approach: When and How?

Presenter: Masahiko Ochiai, Atsunori Okamura

October 29, 2017

Presentation TCT 2017

Use of the Transradial Approach in Complex CTO Interventions

Presenter: Masahiko Ochiai, Atsunori Okamura, Yutaka Tanaka

October 29, 2017

Presentation TCT 2017

Preprocedural Evaluation of CTO by MSCT

Presenter: Masahiko Ochiai, Atsunori Okamura, Masaaki Okutsu

October 29, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

L.A. McKeown

May 15, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

Presentation Fellows 2017

The Evolution of Drug-Eluting Stents

Presenter: Ajay J. Kirtane

April 07, 2017

News Daily News

Transfemoral PCI More Successful in Treating CTOs, Especially Complex Lesions

Yael L. Maxwell

February 07, 2017

Presentation CHIP Florida 2017

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Presenter: David E. Kandzari

January 20, 2017

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

Presentation TCT 2016

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Presenter: Ron Waksman, Robert-Jan van Geuns, Michael Haude

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Presenter: Dean J. Kereiakes, Pieter C. Smits

October 30, 2016

Advertisement

Emerging Thromboresistant BMS 1: Cobra PzF Stents

Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Impact of Antegrade Dissection and Re-entry in Japanese CTO Interventions

IVUS-Guided Rewiring in the Antegrade Approach: When and How?

Use of the Transradial Approach in Complex CTO Interventions

Preprocedural Evaluation of CTO by MSCT

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

TCTMD’s Top 10 Most Popular Stories for July 2017

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Bioresorbable Scaffolds: Where Do We Go From Here?

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

The Evolution of Drug-Eluting Stents

Transfemoral PCI More Successful in Treating CTOs, Especially Complex Lesions

Evolution of Left Main Percutaneous Revascularization Advancement to a Standard of Care

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

AMS/Dreams Evolution to Magmaris: Latest Outcomes With Magnesium-Based Stents

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content